Capricor Therapeutics (CAPR) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.57
-0.43
-0.3
-0.16

Details

Expected EPS
-0.546667
Actual EPS
-0.54
Surprise EPS
0.01
Surprise Percent
+1.22%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.54 per share for Q4 2025.

0 Comments

Share your thoughts